Tuesday, 25 November 2014

Global pharmaceutical firm joins Rwanda in cancer fight

Rwanda could soon be one of the first countries in Africa to venture into clinical trial tests and research for cancer and other diagnostic diseases.

This follows an exploratory visit by Robert Mulroy, the CEO of Merrimack Pharmaceuticals, a biopharmaceutical company involved in developing and preparing innovative medicines for the treatment of serious diseases, amongst them cancer.

Mulroy was in the country on a three-day visit that ended Thursday, during which he held meetings with top government officials, including the CEO of Rwanda Development Board, Francis Gatare.

He also interacted with senior officials from the Ministry of Health to discuss key possible areas of partnership, most especially in the areas of clinical research tests. Read More...


Post a Comment